Development and Validation of an Improved, COPD-Specific Version of the St. George Respiratory Questionnaire
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Objective To produce an improved, COPD-specific version of the St. George respiratory questionnaire (SGRQ-C).Methods Five different steps were required: (1) Rasch analysis of the responses of 893 COPD patients to the St. George respiratory questionnaire (SGRQ) identified weaker items to be removed; (2) a scoring algorithm was produced using data from 1,036 patients; (3) validity of the new and original SGRQ was tested using data from the original validation study; (4) responsiveness was tested using data from a previously published trial; and (5) a reworded version (SGRQ-C) that no longer specified the recall period was administered to 63 pulmonary rehabilitation participants.Results Items were removed due to lack of response (n = 1), misfit to the Rasch model (n = 8), and disordered responses (n = 1). Another six items had disordered responses; this was corrected. Scores from the two versions differed slightly, so the scoring algorithm was revised to produce scores equivalent to the original. Intraclass correlation coefficient (ICCC) for the scores for original and new versions was 0.99. Correlations with other measures of disease were very similar to those obtained with the original. New and original scores for treatment effects were similar: difference, 0.1 +/- 2.7 U (+/- SD). Baseline SGRQ and SGRQ-C scores were similar (ICCC, 0.95; 95% confidence interval, 0.92 to 0.97; mean difference, 0.9 +/- 5.8 U). Change scores were similar (difference, 1.0 +/- 7.3 U).Conclusions The SGRQ-C contains the best of the original items, no longer specifies a recall period, and produces scores equivalent to the original.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“A review of the SGRQ undertaken to create a more appropriate instrument for use in patients with COPD identified 26 items that required modification.34”
From Cognitive behavioral therapy for management of dyspnea: A pilot study (2015) · cites this paper as [34]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT
Martin Bland, J., & Altman, D. (1986) · The Lancet · doi:10.1016/s0140-6736(86)90837-8 · Cited by 47,965
(1965) · The Lancet · doi:10.1016/s0140-6736(65)91037-8 · Cited by 16,856
Probabilistic Models for Some Intelligence and Attainment Tests
(1961) · Information and Control · doi:10.1016/s0019-9958(61)80061-2 · Cited by 6,939
Jones, P. W., Quirk, F. H., Baveystock, C. M., & Littlejohns, P. (1992) · American Review of Respiratory Disease · doi:10.1164/ajrccm/145.6.1321 · Cited by 3,035
Self-citationAndrich, D. (1988) · doi:10.4135/9781412985598 · Cited by 1,345
A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease
Casaburi, R., Mahler, D. A., Jones, P. W., Wanner, A., San Pedro, G., ZuWallack, R. L., Menjoge, S. S., Serby, C. W., & Witek, T. (2002) · European Respiratory Journal · doi:10.1183/09031936.02.00269802 · Cited by 881
Self-citationDevelopment and validation of the Mini Asthma Quality of Life Questionnaire
Juniper, E. F., Guyatt, G. H., Cox, F. M., Ferrie, P. J., & King, D. R. (1999) · European Respiratory Journal · doi:10.1034/j.1399-3003.1999.14a08.x · Cited by 786
Quality of life changes in COPD patients treated with salmeterol.
Jones, P. W., & Bosh, T. K. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.155.4.9105068 · Cited by 494
Self-citationAmerican translation, modification, and validation of the St. George's Respiratory Questionnaire
Barr, J. T., Schumacher, G. E., Freeman, S., LeMoine, M., Bakst, A. W., & Jones, P. W. (2000) · Clinical Therapeutics · doi:10.1016/s0149-2918(00)80089-2 · Cited by 180
Self-citationBurge, P. S. (2003) · Thorax · doi:10.1136/thorax.58.8.654 · Cited by 154
Cited by
Items 101–200 of 350
Nam, J. G., Kang, H.-R., Lee, S. M., Kim, H., Rhee, C., Goo, J. M., Oh, Y., Lee, C., & Park, C. M. (2022) · Radiology · doi:10.1148/radiol.212071 · Cited by 47
Siler, T. M., Nagai, A., Scott-Wilson, C. A., Midwinter, D., & Crim, C. C. (2016) · Respiratory Medicine · doi:10.1016/j.rmed.2016.12.001 · Cited by 38
Anderson, W. H., Ha, J. W., Couper, D. J., O’Neal, W. K., Barr, R. G., Bleecker, E. R., Carretta, E. E., Cooper, C. B., Doerschuk, C. M., Drummond, M., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0184606 · Cited by 37
Long-term safety of bilateral targeted lung denervation in patients with COPD
Valipour, A., Asadi, S., Pison, C. M., Jondot, M., Kessler, R., Bennedif, K., Deslée, G., Verdier, M., Slebos, D., & Mayse, M. L. (2018) · International Journal of COPD · doi:10.2147/copd.s158748 · Cited by 39
Farmer, A. A., Toms, C., Hardinge, M., Williams, V., Rutter, H., & Tarassenko, L. (2014) · BMJ Open · doi:10.1136/bmjopen-2013-004437 · Cited by 40
“The research nurse randomises the patient by accessing Sortition using a web-browser on a tablet computer at the assessment visit only after completion of consent procedures and baseline measurements, including completion of the SGRQ-C.”
BackgroundInfluentialOkutan, O., Taş, D., Demirer, E., & Kartaloğlu, Z. (2013) · Yonsei Medical Journal · doi:10.3349/ymj.2013.54.5.1214 · Cited by 35
Houben‐Wilke, S., Spruit, M. A., Uszko‐Lencer, N. H. M. K., Otkinska, G., Vanfleteren, L. E. G. W., Jones, P., Wouters, E. F. �., & Franssen, F. M. E. (2016) · Respirology · doi:10.1111/resp.12968 · Cited by 35
Self-citationEnsifentrine as a Novel, Inhaled Treatment for Patients with COPD
Donohue, J. F., Rheault, T., MacDonald-Berko, M., Bengtsson, T., & RICKARD, K. A. (2023) · International Journal of COPD · doi:10.2147/copd.s413436 · Cited by 34
Chronic cough as a novel phenotype of chronic obstructive pulmonary disease
Koo, H., Park, S., Park, J.-W., Choi, H. S., Kim, T., Yoon, H. K., Yoo, K. H., Jung, K.-S., & Kim, D. K. (2018) · International Journal of COPD · doi:10.2147/copd.s153821 · Cited by 38
“SGRQ-C is a 14-item questionnaire that provides a total score as well as scores for the following three components: symptoms, activities, and impacts.(16) Total and component scores were calculated according to algorithms provided in the SGRQ-C instruction manual.”
van Haarst, A. D., McGarvey, L. P., & Paglialunga, S. (2019) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1540 · Cited by 41
“The SGRQ is a validated self-administered 50-item questionnaire with weighted responses for a 3-month or 4-week recall period,(36) and a shorter COPD-specific version also exists.(37) The questionnaire evaluates the frequency and severity of a patient’s symptoms, the extent their disease affects their daily activities…”
MethodIrwin, D. E., Atwood, C. A., Hays, R. D., Spritzer, K. L., Liu, H., Donohue, J. F., Leidy, N. K., Yount, S., & DeWalt, D. A. (2014) · Quality of Life Research · doi:10.1007/s11136-014-0818-1 · Cited by 36
Cross-national comparison of twelve quality of life instruments
Richardson, J. R. J. (2012) · Cited by 52
Effect of hypertonic saline on mucociliary clearance and clinical outcomes in chronic bronchitis
Bennett, W. D., Henderson, A. G., Ceppe, A., Zeman, K. L., Wu, J., Gladman, C., Fuller, F., Gazda, S., Button, B. M., Boucher, R. C., et al. (2020) · ERJ Open Research · doi:10.1183/23120541.00269-2020 · Cited by 36
Ausín, P., Martínez‐Llorens, J., Bresco, M. S., Casadevall, C., Barreiro, E., & Gea, J. (2016) · Chronic Respiratory Disease · doi:10.1177/1479972316674412 · Cited by 43
Once-Daily Triple Therapy in Patients with COPD: Patient-Reported Symptoms and Quality of Life
Tabberer, M. M., Lomas, D. A., Birk, R., Brealey, N., Zhu, C., Pascoe, S., Locantore, N., & Lipson, D. A. (2018) · Advances in Therapy · doi:10.1007/s12325-017-0650-4 · Cited by 32
“SGRQ-C [14] Day 1, week 4 and 24, week 52”
BackgroundThe St George’s Respiratory Questionnaire revisited: a psychometric evaluation
Paap, M. C. S., Brouwer, D., Glas, C. A. W., Monninkhof, E. M., Forstreuter, B., Pieterse, M. E., & van der Palen, J. A. M. (2013) · Quality of Life Research · doi:10.1007/s11136-013-0570-y · Cited by 34
The BSS - A Valid Clinical Instrument to Measure the Severity of Acute Bronchitis
Kardos, P., Lehrl, S., Matthys, H., & Kamin, W. (2014) · Journal of Lung Pulmonary & Respiratory Research · doi:10.15406/jlprr.2014.01.00016 · Cited by 31
Hareendran, A., Palsgrove, A. C., Mocarski, M., Schaefer, M. L., Setyawan, J., Carson, R. T., & Make, B. J. (2013) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-11-104 · Cited by 31
“At the close of the focus group discussions, each participant completed health status and sociodemographic questionnaires, including the St. George’s Respiratory Questionnaire for COPD Patients (SGRQ-C) [15,16] and the Hospital Anxiety and Depression Scale (HADS) [17,18].”
MethodExuzides, A., Colby, C., Briggs, A. H., Lomas, D. A., Mölken, M. R., Tabberer, M. M., Chambers, M. G., Muellerova, H., Locantore, N., Risebrough, N. A., et al. (2015) · Medical Decision Making · doi:10.1177/0272989x15610781 · Cited by 35
“The SGRQ total score was derived from the SGRQ for COPD (SGRQ-C) questionnaire.(16) Due to the time-dependent nature of the longitudinal variables (i.”
MethodTabberer, M. M., Gonzalez‐McQuire, S., Muellerova, H., Briggs, A. H., Mölken, M. R., Chambers, M. G., & Lomas, D. A. (2016) · Medical Decision Making · doi:10.1177/0272989x16662009 · Cited by 32
Heo, I. R., Kim, H. C., & Kim, T. H. (2020) · Medicina · doi:10.3390/medicina57010004 · Cited by 35
“While the St. George’s Respiratory Questionnaire (SGRQ) has been applied as an important outcome measure in COPD [10,11], the deficits in the HRQOL of patients with PRISm are not well known.”
BackgroundInfluentialPatient reported outcome measures in chronic obstructive pulmonary disease: Which to use?
Ekström, M. P., Sundh, J., & Larsson, K. (2016) · Expert Review of Respiratory Medicine · doi:10.1586/17476348.2016.1146595 · Cited by 32
“A somewhat shorter COPD version with 40 items (C-SGRQ) has been developed [69].”
BackgroundSalvador, A. M., Torres‐Sánchez, I., Sáez-Roca, G., López-Torres, I., Alzueta, E., & Valenza, M. C. (2015) · Archivos de Bronconeumología · doi:10.1016/j.arbr.2015.06.002 · Cited by 28
Behnia, M. M., Wheatley, C. M., Avolio, A. P., & Johnson, B. D. (2018) · Nitric Oxide · doi:10.1016/j.niox.2018.03.009 · Cited by 29
Janssen, D. J. A., Müllerová, H., Agustí, A. G. N., Yates, J., Tal‐Singer, R., Rennard, S. I., Vestbo, J., & Wouters, E. F. �. (2014) · Respiratory Medicine · doi:10.1016/j.rmed.2014.07.013 · Cited by 27
“Total scores range from 0 (no impairment) to 100 (worst possible health status) points [21].”
BackgroundBiological effects of p38 MAPK inhibitor losmapimod does not translate to clinical benefits in COPD
Pascoe, S. J., Costa, M. J., Marks-Kończalik, J., McKie, E., Yang, S., & Scherbovsky, P. S. (2017) · Respiratory Medicine · doi:10.1016/j.rmed.2017.07.002 · Cited by 26
Health-related quality of life of COPD patients aged over 40 years
Fazekas‐Pongor, V., Fekete, M., Balázs, P., Árva, D., Pénzes, M., Tarantini, S., Urbán, R., & Varga, J. T. (2021) · Physiology International · doi:10.1556/2060.2021.00017 · Cited by 27
“Scores range from 0 to 100 with higher scores indicating more severe symptoms/limitations [17].”
BackgroundMethodInfluentialCohort Profile: The Birmingham Chronic Obstructive Pulmonary Disease (COPD) Cohort Study
Adab, P., Fitzmaurice, D. A., Dickens, A., Ayres, J. G., Buni, H., Cooper, B. G., Daley, A., Enocson, A., Greenfield, S., Jolly, K. B., et al. (2016) · International Journal of Epidemiology · doi:10.1093/ije/dyv350 · Cited by 31
Mesquita, R., Franssen, F. M. E., Houben‐Wilke, S., Uszko‐Lencer, N. H. M. K., Vanfleteren, L. E. G. W., Goërtz, Y. M. J., Pitta, F. D. O., Wouters, E. F. �., & Spruit, M. A. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.10.016 · Cited by 33
Bansal, S., Anderson, M. P., Anzueto, A., Brown, N., Compton, C. H., Corbridge, T. C., Erb, D., Harvey, C., Kaisermann, M. C., Kaye, M. G., et al. (2021) · npj Primary Care Respiratory Medicine · doi:10.1038/s41533-021-00241-z · Cited by 26
Giorgio, A. D., Dante, A., Cavioni, V., Padovan, A. M., Rigonat, D., Iseppi, F., Graceffa, G., & Gulotta, F. (2017) · Frontiers in Psychology · doi:10.3389/fpsyg.2017.01682 · Cited by 29
Rehman, A. U., Hassali, M. A., Harun, S. N., Abbas, S., Muneswarao, J., Ali, I. A. H., & Hussain, R. (2020) · Health and Quality of Life Outcomes · doi:10.1186/s12955-020-01393-1 · Cited by 28
for the COSYCONET Study Group, Lutter, J. I., Jörres, R. A., Kahnert, K., Schwarzkopf, L., Studnicka, M., Karrasch, S., Schulz, H., Vogelmeier, C. F., & Holle, R. (2020) · BMC Pulmonary Medicine · doi:10.1186/s12890-020-1147-5 · Cited by 26
“At each visit, HRQL was assessed using two selfadministered questionnaires: the generic 3-level version of Euro-Qol 5D (EQ-5D-3 L) and the disease-specific Saint George’s Respiratory Questionnaire for COPD (SGRQ) [18, 19].”
MethodPanahi, Y., Ghanei, M., Vahedi, E., Ghazvini, A., Parvin, S., Madanchi, N., Bagheri, M., & Sahebkar, A. (2013) · Journal of Immunotoxicology · doi:10.3109/1547691x.2013.797525 · Cited by 26
“Each sub-scale as well as total score ranges between 0–100, with higher scores indicative of more severe impairments to the quality-of-ife due to disease (Meguro et al., 2007).”
BackgroundMethodPhysical Activity, Depression and Quality of Life in COPD – Results from the CLARA II Study
Horner, A., Olschewski, H., Hartl, S., Valipour, A., Funk, G., Studnicka, M., Merkle, M., Kaiser, B., Wallner, E. M., Brecht, S., et al. (2023) · International Journal of COPD · doi:10.2147/copd.s435278 · Cited by 30
“8 It consists of a total score and the domains activity, symptoms, and impact on daily life.”
BackgroundMethodMcNamara, R. J., Houben‐Wilke, S., Franssen, F. M. E., Smid, D. E., Vanfleteren, L. E. G. W., Groenen, M. T. J., Uszko‐Lencer, N. H. M. K., Wouters, E. F. �., Alison, J. A., & Spruit, M. A. (2018) · Respiratory Medicine · doi:10.1016/j.rmed.2018.03.032 · Cited by 27
Horner, A., Burghuber, O. C., Hartl, S., Studnicka, M., Merkle, M., Olschewski, H., Kaiser, B., Wallner, E. M., & Lamprecht, B. (2020) · International Journal of COPD · doi:10.2147/copd.s252033 · Cited by 24
Assessing exertional dyspnea in patients with idiopathic pulmonary fibrosis
Swigris, J. J., Streiner, D. L., Brown, K. K., Belkin, A., Green, K. E., & Wamboldt, F. S. (2013) · Respiratory Medicine · doi:10.1016/j.rmed.2013.12.009 · Cited by 28
Humanistic and socioeconomic burden of COPD patients and their caregivers in Malaysia
Rehman, A. U., Muhammad, S. A., Tasleem, Z., Alsaedi, A., Dar, M., Iqbal, M. O., Rasool, M. F., Shah, S., Abbas, G., Shakeel, S., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-01551-5 · Cited by 29
Zhou, Q., Mei, J., He, B., Huang, S.-G., Shi, Y., Wen, F., & Zhao, M.-W. (2013) · Chinese Medical Journal · doi:10.3760/cma.j.issn.0366-6999.20121090 · Cited by 23
Factors associated with exacerbation in mild-to-moderate COPD patients
Kim, J. K., Lee, S. H., Lee, B. H., Lee, C. Y., Kim, D.-J., Min, K. H., Kim, S.-K., Yoo, K. H., Jung, K., & Hwang, Y. I. (2016) · International Journal of COPD · doi:10.2147/copd.s105583 · Cited by 24
Diaphragm Morphology Assessed by Computed Tomography in Chronic Obstructive Pulmonary Disease
Donovan, A. A., Johnston, G. P., Moore, M., Jensen, D., Benedetti, A., Coxson, H. O., Gottfried, S. B., Petrof, B. J., Bourbeau, J., & Smith, B. M. (2021) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202007-865oc · Cited by 28
Aabenhus, R. M., Thorsen, H., Siersma, V., & Brodersen, J. (2013) · Value in Health · doi:10.1016/j.jval.2013.06.011 · Cited by 22
“The number of items (43) is comparable to other research questionnaires [15,18] as is time of completion (5 minutes).”
BackgroundResultVALIDITY OF CAT AND MMRC – DYSPNEA SCORE IN EVALUATION OF COPD SEVERITY
Milačić, N., Milačić, B., Dunjić, O., & Milojković, M. (2015) · Acta Medica Medianae · doi:10.5633/amm.2015.0111 · Cited by 22
“They respond to broad spectrum of therapeutical interventions and can give us insight into the treatment clinical efficacy (19,20).”
BackgroundDifferential Impact of Low Fat-Free Mass in People With COPD Based on BMI Classifications
Machado, F. V. C., Vogelmeier, C. F., Jörres, R. A., Watz, H., Bals, R., Welte, T., Spruit, M. A., Alter, P. J., & Franssen, F. M. E. (2022) · CHEST Journal · doi:10.1016/j.chest.2022.11.040 · Cited by 27
Mahaffey, B., Mackin, D. M., Vranceanu, A., Lofaro, L., Bromet, E. J., Luft, B. J., & Gonzalez, A. (2018) · Journal of Health Psychology · doi:10.1177/1359105318787024 · Cited by 23
“The St. George’s Respiratory Questionnaire for COPD Patients (SGRQ-C; Meguro et al., 2007) is a 40-item self-report questionnaire designed to assess the presence of lower respiratory symptoms (LRS) and their impact on daily functioning.”
MethodResultNguyen, H. T., Pavey, T., Collins, P. F., Nhung, N. V., Pham, T. D., & Gallegos, D. (2019) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2019.09.013 · Cited by 31
Lo, C., Liang, W.-M., Hang, L., Wu, T.-C., Chang, Y., & Chang, C. (2015) · Health and Quality of Life Outcomes · doi:10.1186/s12955-015-0320-7 · Cited by 22
“Moreover, each domain of the SGRQ reported good person reliability and separation, except the Symptom domain, which is similar to the result of CTT analysis in the previous study [37] and by IRT [36].”
BackgroundResultInfluentialon behalf of STORICO study group, Scichilone, N., Incalzi, R. A., Blasi, F., Schino, P., Cuttitta, G., Zullo, A., Ori, A., & Canonica, G. W. (2019) · BMC Pulmonary Medicine · doi:10.1186/s12890-019-0935-2 · Cited by 21
Hoogendoorn, M., Jowett, S. M., Dickens, A., Jordan, R., Enocson, A., Adab, P., Versteegh, M., & Mölken, M. R. (2021) · Value in Health · doi:10.1016/j.jval.2021.05.006 · Cited by 21
Agado, B. E., Crawford, B., DeLaRosa, J., Bowen, D. M., Peterson, T. S., Neill, K. S., & Paarmann, C. (2012) · PubMed · Cited by 26
Clinical assessment tests in evaluating patients with chronic obstructive pulmonary disease
Chuang, M., Lin, I., & Lee, C.-Y. (2016) · Medicine · doi:10.1097/md.0000000000005471 · Cited by 20
Czarnota, P., MacLeod, J. L., Gupta, N., Manichaikul, A. W., & Shim, Y. M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26062747 · Cited by 28
“The GOLD 2024 report highlights the COPD Assessment Test (CAT) and St George’s Respiratory Questionnaire (SGRQ) as tools to assess symptoms [1,6,7].”
Pothirat, C., Kiatboonsri, S., & Chuchottaworn, C. (2014) · BMC Pulmonary Medicine · doi:10.1186/1471-2466-14-193 · Cited by 19
“The questionnaire was self-completed by patients over an average of 20 minutes [12].”
Paap, M. C. S., Lange, L., van der Palen, J. A. M., & Bode, C. (2015) · Quality of Life Research · doi:10.1007/s11136-015-1192-3 · Cited by 21
The Mysuru stUdies of Determinants of Health in Rural Adults (MUDHRA), India
Mahesh, P. A., Lokesh, K. S., Madhivanan, P., Chaya, S. K., Siddaiah, J. B., Ganguly, K., & Krishna, M. (2018) · Epidemiology and Health · doi:10.4178/epih.e2018027 · Cited by 19
“Georg’s Respiratory Questionnaire [34],”
Long-Term Patient-Centred Follow-up in a Prospective Cohort of Patients with COVID-19
Righi, E., Mirandola, M., Mazzaferri, F., Razzaboni, E., Zaffagnini, A., Erbogasto, A., Vecchia, I. D., Auerbach, N., Ivaldi, F., Mongardi, M., et al. (2021) · Infectious Diseases and Therapy · doi:10.1007/s40121-021-00461-3 · Cited by 23
Airway pathogens detected in stable and exacerbated COPD in patients in Asia-Pacific
Taddei, L., Malvisi, L., Hui, D. S. C., Malvaux, L., Samoro, R. Z., Lee, S. H., Yeung, Y. C., Liu, Y., & Arora, A. K. (2022) · ERJ Open Research · doi:10.1183/23120541.00057-2022 · Cited by 19
“For each questionnaire, higher scores reflect worse health status [26, 27].”
Endobronchial Valves Therapy for Advanced Emphysema
Low, S., Lee, J. Z., DESAI, H. H., Hsu, C., Sam, A., & Knepler, J. L. (2018) · Journal of Bronchology & Interventional Pulmonology · doi:10.1097/lbr.0000000000000527 · Cited by 18
Defining Chronic Mucus Hypersecretion Using the CAT in the SPIROMICS Cohort
Stott‐Miller, M., Müllerová, H., Miller, B. E., Tabberer, M. M., Baou, C. E., Keeley, T., Martínez, F. J., Han, M. K., Dransfield, M. T., Hansel, N. N., et al. (2020) · International Journal of COPD · doi:10.2147/copd.s267002 · Cited by 18
Svedsäter, H., Leather, D. A., Robinson, T., Doll, H., Nafees, B., & Bradshaw, L. (2017) · Respiratory Medicine · doi:10.1016/j.rmed.2017.09.010 · Cited by 17
Ibrahim, S., Manu, M. K., James, B. S., Kamath, A., & Shetty, R. S. (2021) · Clinical Epidemiology and Global Health · doi:10.1016/j.cegh.2021.100711 · Cited by 17
Dong, X., Wang, X., Jia, N., Chen, X., & Ding, M. (2021) · Medicine · doi:10.1097/md.0000000000026010 · Cited by 21
Kaymaz, D., Ergün, P., Demirci, E., & Demir, N. (2015) · Tuberkuloz ve Toraks · doi:10.5578/tt.8493 · Cited by 17
Lawrence, P. J., Kolsum, U., Gupta, V., Donaldson, G. C., Singh, R., Barker, B., George, L., Webb, A. J., Brookes, A. J., Brightling, C. E., et al. (2017) · BMC Pulmonary Medicine · doi:10.1186/s12890-017-0384-8 · Cited by 17
Mohsen, S., Hanafy, F., Fathy, A., & El‐Gilany, A. (2019) · Lung India · doi:10.4103/0970-2113.257719 · Cited by 17
Park, S., Saiphoklang, N., Jung, D., Gómez, D., Phillips, J. E., Dolezal, B. A., Tashkin, D. P., Barjaktarević, I., & Cooper, C. B. (2022) · Sensors · doi:10.3390/s22062264 · Cited by 19
“status in COPD and other respiratory diseases [32]; and COPD Assessment Test (CAT), which is used for assessing disease-specific quality of life for COPD patients [33].”
MethodDevelopment and validation of the Asthma Life Impact Scale (ALIS)
Meads, D. M., McKenna, S. P., Doward, L. C., Pokrzywinski, R. M., Revicki, D. A., Hunter, C. J., & Glendenning, G. A. (2010) · Respiratory Medicine · doi:10.1016/j.rmed.2009.11.023 · Cited by 17
Pulmonary Rehabilitation and Chronic Lung Disease: Opportunities for the Respiratory Therapist
Carlin, B. W. (2009) · Respiratory Care · doi:10.4187/respcare.09541091 · Cited by 18
Whelan, M., Velardo, C., Rutter, H., Tarassenko, L., & Farmer, A. A. (2019) · JMIR mhealth and uhealth · doi:10.2196/14946 · Cited by 16
“Age, sex, body mass index (BMI), COPD severity using the Global Initiative for Chronic Obstructive Lung Disease (GOLD) staging [31], Forced Expiratory Volume in 1 second (FEV1%), health status using the EuroQol 5-Dimension Questionnaire (EQ-5D) [32], symptoms of anxiety and depression using the Symptom Checklist (SCL1…”
MethodMoon, S. M., Lim, J. H., Hong, Y. S., Shin, K. C., Lee, C. Y., Kim, D.-J., Lee, S. H., Jung, K. S., Lee, C., Yoo, K. H., et al. (2021) · Journal of Thoracic Disease · doi:10.21037/jtd-20-1098a · Cited by 17
“BMI ≥25 kg/m(2), n [%] 123 [24] 159 [42] <0.”
Wilcox, T. K., Chen, W.-H., Howard, K. A., Wiklund, I. E., Brooks, J., Watkins, M. L., Cates, C. E., Tabberer, M. M., & Crim, C. C. (2013) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-11-196 · Cited by 17
“At Visit 1, patients completed a Table 2 Study assessments Criterion measuresa Study visit 1 (Day 1) Daily on eDiary (Days 1–28) Weekly on eDiary Study visit 2 (Day 29 + 3) Participant-completed CRQ-SAS X X SGRQ-C X X mMRC dyspnea severity X X Global Assessment of Shortness of Breath X PGAC X Clinician-completed mMRC…”
BackgroundMethodInfluentialAlveolar–capillary reserve during exercise in patients with chronic obstructive pulmonary disease
Behnia, M. M., Wheatley, C. M., Avolio, A. P., & Johnson, B. D. (2017) · International Journal of COPD · doi:10.2147/copd.s142523 · Cited by 18
“After reporting to the outpatient clinic, study participants filled out the St George’s Respiratory Questionnaire (SGRQ) to measure quality of life (QOL) and performed PFTs which included resting measures of maximal lung volumes and flow rates using classical spirometry.(14,15) In addition, the assessment of DLCO was…”
MethodSingle-Inhaler Triple Therapy and Health-Related Quality of Life in COPD: The IMPACT Study
Tabberer, M. M., JONES, C. E., Kilbride, S., Halpin, D. M. G., Lomas, D. A., Pascoe, S. J., Singh, D., Wise, R. A., Criner, G. J., Lange, P., et al. (2020) · Advances in Therapy · doi:10.1007/s12325-020-01409-8 · Cited by 16
“SGRQ-C, which contains 40 items grouped into three domains to measure the impact of COPD and its treatment on HRQoL [11], was completed at ran-”
MethodNemiralisib in Patients with an Acute Exacerbation of COPD: Placebo-Controlled, Dose-Ranging Study
Fahy, W. A., Homayoun-Valiani, F., Cahn, A. P., Robertson, J., Templeton, A. G. B., Meeraus, W. H., Wilson, R., Lowings, M., Marotti, M., West, S. L., et al. (2021) · International Journal of COPD · doi:10.2147/copd.s309320 · Cited by 16
A Scoring Application for the St. George’s Respiratory Questionnaire
Gelpi, M., Argentiero, J., Jones, P., & Ronit, A. (2016) · CHEST Journal · doi:10.1016/j.chest.2016.05.029 · Cited by 18
“The intention with this revision was to improve the signal to noise of the calculated scores by removing items that had weaker instrument properties, and at the same time produce scores equivalent to the SGRQ without specifying a recall period.(3) The scoring algorithm for the SGRQ and SGRQC has been described in deta…”
ResultSelf-citationCognitive behavioral therapy for management of dyspnea: A pilot study
Williams, M. T., Cafarella, P., Paquet, C., & Frith, P. (2015) · Respiratory Care · doi:10.4187/respcare.03764 · Cited by 15
Singh, P., Salman, K. A., Shameem, M., & Warsi, M. S. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.901710 · Cited by 18
“To avoid any chances of bias, the questionnaire was filled before PFT. Jones, the author of the questionnaire, considered four unit decrease as the minimal clinically significant reduction (Meguro et al., 2007).”
BackgroundMapping the COPD Assessment Test onto EQ-5D
Hoyle, C. K., Tabberer, M., & Brooks, J. (2016) · Value in Health · doi:10.1016/j.jval.2016.01.005 · Cited by 15
“[9] Meguro M, Barley EA, Spencer S, Jones PW.”
BackgroundMethodTajti, G., Papp, C., Kardos, L., Kéki, S., Pák, K., Szilasi, M. E., Gesztelyi, R., Mikáczó, A., Fodor, A., Szilasi, M., et al. (2018) · Allergy Asthma and Clinical Immunology · doi:10.1186/s13223-017-0226-5 · Cited by 15
“George’s Respiratory questionnaire (SGRQ) [29] after obtaining written permission from its proprietor (permission issued by Paul Jones, University of London, London, UK, on August 28 2012).”
MethodValidation of the Saint George’s Respiratory Questionnaire in Uganda
Morgan, B. W., Grigsby, M. R., Siddharthan, T., Kalyesubula, R., Wise, R. A., Hurst, J. R., Kirenga, B., & Checkley, W. (2018) · BMJ Open Respiratory Research · doi:10.1136/bmjresp-2018-000276 · Cited by 15
Gonçálves, J. M. F., Martínez, M. D. M., Pérez‐Méndez, L., Bello, M. Á. G., García‐Talavera, I., Hernández, S., Díaz-Pérez, D., & Martín, N. B. (2018) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.1080/15412555.2018.1531388 · Cited by 15
“The HEED study (35) showed that dyspnea is present even in the mildest stages of the disease and, along with comorbidities, is one of the factors closely linked to health status measured both through the St. George’s Respiratory Questionnaire (SGRQ) (36) and the CAT questionnaire (23).”
BackgroundInfluentialSalvador, A. M., Torres‐Sánchez, I., Sáez-Roca, G., López-Torres, I., Alzueta, E., & Valenza, M. C. (2015) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2014.11.009 · Cited by 18
Tajti, G., Gesztelyi, R., Pák, K., Papp, C., Kéki, S., Szilasi, M. E., Mikáczó, A., Fodor, A., Szilasi, M., & Zsuga, J. (2017) · International Journal of COPD · doi:10.2147/copd.s127373 · Cited by 15
“All SGRQ scores were substantially higher in the worse-controlled group (showing greater health impairment and poorer quality of life) (Table 2).”
InfluentialSzilasi, M. E., Pák, K., Kardos, L., Varga, V. E., Seres, I., Mikáczó, A., Fodor, A., Szilasi, M., Tajti, G., Papp, C., et al. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00653 · Cited by 16
“Correlation analysis as well as simple and multiple linear regression were used to assess the relationship between the irisin level and the Impacts score of SGRQ, which latter is indicative of the presence and severity of distress disorder.”
MethodInfluentialNiyatiwatchanchai, N., Pothirat, C., Chaiwong, W., Liwsrisakun, C., Phetsuk, N., Duangjit, P., & Choomuang, W. (2022) · International Journal of Environmental Health Research · doi:10.1080/09603123.2022.2063263 · Cited by 15
“Each domain has a score ranging from 0 to 100, where the higher score indicates worse health (Meguro et al. 2007).”
BackgroundMethodInfluentialAu, D. H., Gleason, E., Hunter‐Merrill, R. A., Barón, A. E., Collins, M. P., Ronneberg, C. R., Lv, N., Rise, P. J., Wai, T. H., Plumley, R., et al. (2023) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202305-458oc · Cited by 16
Accuracy of Expected Symptoms and Subsequent Quality of Life Measures Among Adults With COPD
Hart, J. L., Summer, A., Ogunduyile, L., Lapite, F. C., Hong, D., Whitman, C., Blette, B. S., Harhay, M. O., & Halpern, S. D. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.44030 · Cited by 18
Paap, M. C. S., Kroeze, K. A., Terwee, C. B., van der Palen, J. A. M., & Veldkamp, B. P. (2017) · Quality of Life Research · doi:10.1007/s11136-017-1624-3 · Cited by 13
Gagné, M. E., Lauzier, S., Babineau-Therrien, J., Hamel, C., Penney, S.-E., Bourbeau, J., Moisan, J., & Boulet, L. (2019) · Patient · doi:10.1007/s40271-019-00386-7 · Cited by 19
Garrow, A. P., Khan, N. U., Tyson, S. F., Vestbo, J., Singh, D., & Yorke, J. (2015) · Thorax · doi:10.1136/thoraxjnl-2014-206410 · Cited by 14
Agustí, A. G. N., Soler‐Cataluña, J. J., Molina, J., Morejón, E., Garcı́a-Losa, M., Roset, M., & Badia, X. C. (2015) · Quality of Life Research · doi:10.1007/s11136-015-0983-x · Cited by 13
Veerapaneni, V. V., Upadhyay, S., Thimraj, T. A., Siddaiah, J. B., Chaya, S. K., Lokesh, K. S., Thimmulappa, R. K., Palmberg, L., Ganguly, K., & Mahesh, P. A. (2021) · Toxics · doi:10.3390/toxics9090208 · Cited by 12
Short, Simple, but Still of Uncertain Value
Kaplan, R. M. (2012) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.3109/15412555.2012.651935 · Cited by 12
Canonica, G. W., Blasi, F., Scichilone, N., Simoni, L., Zullo, A., Giovannetti, C., Briguglio, C., Barsanti, S., & Incalzi, R. A. (2017) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2017.05.021 · Cited by 12
Park, H. Y., Lee, H. J., Kang, D., Choi, H. S., Ryu, Y. H., Jung, K.-S., Sin, D. D., Cho, J., & Yoo, K. H. (2021) · Therapeutic Advances in Chronic Disease · doi:10.1177/2040622320982455 · Cited by 16
BPCO et qualité de vie : impact de la maladie en médecine générale en France
Perez, T., Serrier, P., Pribil, C., & Mahdad, A. (2012) · Revue des Maladies Respiratoires · doi:10.1016/j.rmr.2012.08.005 · Cited by 12
Meys, R., Stoffels, A. A. F., Houben‐Wilke, S., Janssen, D. J. A., Burtin, C., van Hees, H. W. H., Franssen, F. M. E., van den Borst, B., Wouters, E. F. �., & Spruit, M. A. (2020) · Health and Quality of Life Outcomes · doi:10.1186/s12955-020-01505-x · Cited by 13
“To evaluate HRQoL, three disease-specific PROs, the CAT (range 0–40 points) [29], the CCQ (range 0–6 points) [30] and the COPD-specific version of the SGRQ (range 0–100 points) [31] were assessed in all participants.”
MethodDietary Behaviour and Nutrition in Patients with COPD Treated with Long-Term Oxygen Therapy
Mękal, D., Czerw, A. I., & Deptała, A. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph182312793 · Cited by 16
Goossens, L. M. A., Mölken, M. R., Boland, M. R. S., Donkers, B., Jonker, M. F., Slok, A. H. M., Salomé, P. L., van Schayck, O. C. P., Veen, J. C. I. ’., & Stolk, E. A. (2017) · BMJ Open · doi:10.1136/bmjopen-2017-017831 · Cited by 12
Metadata
- Authors
- Meguro, M., Barley, E. A., Spencer, S., & Jones, P. W.
- Affiliations
- St George's, University of London (GB)
- Brunel University of London (GB)
- Corresponding author
- Jones, Paul W.
- Venue
- Chest
- Publisher
- Elsevier BV
- Published
- 2007-08
- Volume
- 132
- Issue
- 2
- Pages
- 456-463
- ISSN
- 0012-3692 (ISSN-L)
- OpenAlex
- W2026656842
- Cited by
- 350
- References
- 16
- Citations by year
- 2026: 11 · 2025: 16 · 2024: 12 · 2023: 15 · 2022: 12 · 2021: 29 · 2020: 26 · 2019: 20 · 2018: 27 · 2017: 36 · 2016: 33 · 2015: 24 · 2014: 22 · 2013: 18 · 2012: 17
- FWCI
- 6.91
- Type
- journal article
- Language
- en
- Open access
- green
- kclpure.kcl.ac.uk
- Licence
- other-oa
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- CHEST Journal (publishedVersion)
- PubMed (publishedVersion)
- Research Portal (King's College London) (publishedVersion, other-oa)
- Edge Hill University Research Information Repository (Edge Hill University) (submittedVersion)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Social Sciences › Decision Sciences › Management Science and Operations Research › Psychometric Methodologies and Testing
- Keywords
- St George's Respiratory Questionnaire, chronic obstructive pulmonary disease, Rasch analysis, scoring algorithm, questionnaire validity, responsiveness, pulmonary rehabilitation, patient-reported outcomes
- MeSH terms
- Aged, Algorithms, Cross-Sectional Studies, Female, Follow-Up Studies, Health Status, Humans, Male, Middle Aged, Quality of Life, Surveys and Questionnaires, Severity of Illness Index, Pulmonary Disease, Chronic Obstructive
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.